Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 178

    1.

    Sural nerve sorbitol in patients with diabetic sensorimotor polyneuropathy.

    Bril V, Ono Y, Buchanan RA.

    Diabetes Care. 2004 May;27(5):1160-3. Review.PMID: 15111538 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Aldose reductase inhibition by AS-3201 in sural nerve from patients with diabetic sensorimotor polyneuropathy.

    Bril V, Buchanan RA.

    Diabetes Care. 2004 Oct;27(10):2369-75.PMID: 15451902 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy. The Tolrestat Study Group.

    Sima AA, Greene DA, Brown MB, Hohman TC, Hicks D, Graepel GJ, Bochenek WJ, Beg M, Gonen B.

    J Diabetes Complications. 1993 Jul-Sep;7(3):157-69.PMID: 8343610 [PubMed - indexed for MEDLINE]Related articles

    4.

    Sorbitol and myo-inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance.

    Sundkvist G, Dahlin LB, Nilsson H, Eriksson KF, Lindgärde F, Rosén I, Lattimer SA, Sima AA, Sullivan K, Greene DA.

    Diabet Med. 2000 Apr;17(4):259-68.PMID: 10821291 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group.

    Greene DA, Arezzo JC, Brown MB.

    Neurology. 1999 Aug 11;53(3):580-91. Erratum in: Neurology 2001 Apr 24;56(8):1124. PMID: 10449124 [PubMed - indexed for MEDLINE]Related articles

    6.

    Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy.

    Perkins BA, Grewal J, Ng E, Ngo M, Bril V.

    Diabetes Care. 2006 Sep;29(9):2023-7.PMID: 16936147 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.
    8.

    Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy.

    Bril V, Perkins BA.

    Diabetes Care. 2002 Nov;25(11):2048-52.PMID: 12401755 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Clinical utility of dorsal sural nerve conduction studies in healthy and diabetic children.

    Turgut N, Karasalihoglu S, Kücükugurluoglu Y, Balci K, Ekuklu G, Tütüncüler F.

    Clin Neurophysiol. 2004 Jun;115(6):1452-6.PMID: 15134714 [PubMed - indexed for MEDLINE]Related articles

    10.

    Medial plantar and dorsal sural nerve conduction studies increase the sensitivity in the detection of neuropathy in diabetic patients.

    Uluc K, Isak B, Borucu D, Temucin CM, Cetinkaya Y, Koytak PK, Tanridag T, Us O.

    Clin Neurophysiol. 2008 Apr;119(4):880-5. Epub 2008 Mar 4.PMID: 18291716 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study.

    Fagius J, Jameson S.

    J Neurol Neurosurg Psychiatry. 1981 Nov;44(11):991-1001.PMID: 6801211 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Overt diabetic neuropathy: repair of axo-glial dysjunction and axonal atrophy by aldose reductase inhibition and its correlation to improvement in nerve conduction velocity.

    Sima AA, Prashar A, Nathaniel V, Bril V, Werb MR, Greene DA.

    Diabet Med. 1993 Mar;10(2):115-21.PMID: 8458187 [PubMed - indexed for MEDLINE]Related articles

    13.

    A comparison of sural nerve conduction studies in patients with impaired oral glucose tolerance test.

    Koçer A, Domaç FM, Boylu E, Us O, Tanridağ T.

    Acta Neurol Scand. 2007 Dec;116(6):399-405.PMID: 17986099 [PubMed - indexed for MEDLINE]Related articles

    14.

    Local human sural nerve blood flow in diabetic and other polyneuropathies.

    Theriault M, Dort J, Sutherland G, Zochodne DW.

    Brain. 1997 Jul;120 ( Pt 7):1131-8.PMID: 9236626 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Simplified electrodiagnostic criteria of diabetic polyneuropathy in field study (KCIS No. 14).

    Hsu WC, Chiu YH, Chen WH, Chiu HC, Liou HH, Chen TH.

    Neuroepidemiology. 2007;28(1):50-5. Epub 2007 Jan 11.PMID: 17215587 [PubMed - indexed for MEDLINE]Related articles

    16.

    Refractory period impairment in sural nerves of diabetics.

    Schütt P, Muche H, Lehmann HJ.

    J Neurol. 1983;229(2):113-9.PMID: 6190996 [PubMed - indexed for MEDLINE]Related articles

    17.

    Emerging therapies for diabetic neuropathy: a clinical overview.

    Perkins BA, Bril V.

    Curr Diabetes Rev. 2005 Aug;1(3):271-80. Review.PMID: 18220603 [PubMed - indexed for MEDLINE]Related articles

    18.

    Comparison of diabetic neuropathy symptom score and medial plantar sensory nerve conduction studies in diabetic patients showing normal routine nerve conduction studies.

    An JY, Park MS, Kim JS, Shon YM, Lee SJ, Kim YI, Lee KS, Kim BJ.

    Intern Med. 2008;47(15):1395-8. Epub 2008 Aug 1.PMID: 18670144 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Superficial radial sensory nerve potentials in immune-mediated and diabetic neuropathies.

    Tamura N, Kuwabara S, Misawa S, Mori M, Nakata M, Hattori T.

    Clin Neurophysiol. 2005 Oct;116(10):2330-3.PMID: 16122982 [PubMed - indexed for MEDLINE]Related articles

    20.

    The reproducibility and sensitivity of sural nerve morphometry in the assessment of diabetic peripheral polyneuropathy.

    Sima AA, Brown MB, Prashar A, Chakrabarti S, Laudadio C, Greene DA.

    Diabetologia. 1992 Jun;35(6):560-9.PMID: 1612230 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data